Disease Model
Disease models are essential tools for studying disease mechanisms, identifying therapeutic targets, and evaluating the efficacy of potential treatments. Creative Bioarray provides a broad range of disease models, including animal disease models, cell-based disease models, and genetically modified disease models.
Humanized Mouse Models: Core Technical Considerations
Tag: Humanized Models
Details: A technical guide to the critical parameters and quality control steps required for robust, long-term human immune cell engraftment in mice.
How to Select the Right Humanized Mouse Model for Immuno-Oncology
Tag: Mouse Models
Details: This comprehensive guide analyzes the selection criteria and key pitfalls of hu-PBMC, hu-HSC, and genetically engineered mouse models, helping scientists precisely match the right humanized platform to their preclinical immuno-oncology pipelines.
How to Match Models to Drug Modalities: Small Molecules vs. Biologics
Tag: Mouse Models
Details: Choosing between syngeneic, CDX, or humanized mice? Learn how drug modality (small molecules vs. biologics) dictates your preclinical in vivo model selection, species cross-reactivity, and translational PK/PD strategy.
Organ-on-a-Chip: Is Your Microfluidic Setup Ready for Preclinical Trials?
Tag: Organ-on-a-Chip, Microfluidics
Details: A technical guide for drug developers on mastering organ chip setup and microfluidics experiment design, providing actionable strategies to ensure high-fidelity chip reproducibility for regulatory-ready preclinical data.
Oncology Model Strategy: From Screening to Validation
Tag: Oncology Model
Details: This guide provides a strategic framework for oncology drug developers to navigate the cancer model workflow-from high-throughput screening to in vivo validation-by matching specific drug mechanisms with the most predictive tumor models to bridge the clinical translation gap.
Why Oncology Organoids Fail? How to Build Models That Work
Tag: Patient-Derived Organoids
Details: A technical deep-dive for R&D professionals that moves past theory to provide "how-to" solutions for the four biggest practical hurdles in organoid research-from sample viability to IND-ready data.
How to Select the Right Preclinical Model for Drug Development
Tag: Preclinical models
Details: This resource provides a comprehensive guide for selecting preclinical models in drug development.
Overview of Cardiovascular Disease Models in Drug Discovery
Tag: Disease models
Details: Cardiovascular diseases (CVDs) remain a significant global health concern, contributing to a substantial burden of morbidity and mortality.
Why Use PDX Models for Cancer Research?
Tag: PDX models
Details: Patient-derived xenograft (PDX) models have emerged as valuable tools in cancer research, offering a unique opportunity to bridge the gap between preclinical and clinical studies.
What Human Disease Models Are Available for Drug Development?
Tag: Disease models
Details: In the field of drug development, the availability of reliable human disease models plays a pivotal role in understanding disease mechanisms, evaluating drug efficacy, and predicting potential toxicities.
Summary of Advantages and Limitations of Different Oncology Animal Models
Tag: Oncology animal models
Details: Oncology research plays a crucial role in understanding cancer biology, developing effective therapies, and improving patient outcomes.
Animal Models of Neurodegenerative Diseases
Tag: Disease models
Details: Studying complex diseases in humans is challenging, which is why animal models serve as valuable tools for understanding their underlying mechanisms and developing potential therapeutic interventions.
Preclinical Models of Acute Liver Failure
Tag: Disease models
Details: Acute liver failure (ALF) is a rare and often heterogeneous presentation of severe liver dysfunction in a patient with otherwise no pre-existing liver disease.
Disease Models of Diabetes Mellitus
Tag: Disease models
Details: Diabetes mellitus, a very common and multifaceted metabolic disorder is considered one of the fastest-growing public health problems in the world.